Article info
PDFLetter
Herpes zoster reactivation after mRNA-1273 vaccination in patients with rheumatic diseases
- Correspondence to Professor Song-Chou Hsieh, Division of Rheumatology, Immunology, and Allergy, Department of Internal Medicine, National Taiwan University Hospital, Taipei 10002, Taiwan; hsiehsc{at}ntu.edu.tw
Citation
Herpes zoster reactivation after mRNA-1273 vaccination in patients with rheumatic diseases
Publication history
- Received October 16, 2021
- Accepted November 26, 2021
- First published December 7, 2021.
Online issue publication
March 10, 2022
Article Versions
- Previous version (7 December 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage